CADL EQUITY Biological Products, (No Disgnostic Substances) 2027 Quantitative Forecast

Candel Therapeutics, Inc. Common Stock (CADL) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$6.20
$-2.19 (-26.1%)
Market Close: Nov 13, 2026
1-Year Base Target
$9.03 +45.6%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$22.11 Bull $24
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$18.79 +203.1% Undervalued
Forward P/E -9.9x • PEG -0.04
AI Quant Stance
HOLD 47/100
RSI 31.1 • MACD Converging • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for CADL

AI Research Note

CADL Price Forecast 2027: Our AI models project that CADL stock will rise to approximately $9.03 by 2027. This represents a potential 45.6% growth from the current trading price of $6.20. The overall market sentiment for CADL is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading CADL shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 31.1, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 46.6/100
Composite Equity Stance
HOLD (Quant Score 47/100) — HOLD (+45.6% 1Y Target Upside)
Active Technical & Price Action Triggers
  • TTM Squeeze just FIRED - potential breakout starting
  • MACD converging near zero line - potential energy building
  • Recent pattern: Closingmarubozu pattern detected
  • Price near support at $6.24
MACD Regime: Converging
Volume Tape: Slight_Accumulation

CADL Trajectory & Forecast Curve

Projected price curve from spot ($6.20) across 30D–3Y horizons

Term Structure of Price Targets

Constant-multiple earnings trajectory model

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $6.43 +3.6%
90 Days 1 Quarter $6.91 +11.4%
6 Months Medium-Term $7.61 +22.8%
1 Year Base Model $9.03 +45.6%
Wall Street 12M Consensus Target: $22.11

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$24.32 +292.3%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$9.03 +45.6%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$6.32 2.0%

Downside scenario if market headwinds or disappointing results

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+203.1% Undervalued
Risk-Adjusted Consensus Fair Value: $18.79
Spot: $6.20

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) indicates CADL trades at a discount to its forward earnings growth trajectory (203.1% implied margin of safety).

PEG Ratio
-0.04
Attractive (<1.0)
Implied Fair P/E
-30.1x
Model Growth 256.6%
Forward P/E
-9.92x
P/S Ratio (TTM)
20709.38x
Market Cap
$642M
52-Week High
$14.00
52-Week Low
$4.35

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Slight_Accumulation
Volume Tape: Slight_Accumulation

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
31.1
Neutral
MACD Signal
Bearish
Primary Trend
Downtrend
Chaikin Money Flow
0.073
Money Flow Index
55.1
200-Day SMA
$10.24

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Strong Alert (Options Flow)
Flow Alert Score
85/100
Tape Classification
Strong Alert (Options Flow)
Unusual Volume Score
80.0
Implied Volatility Spike
+123.4%
Derivative Tape Readout: Short-Term Derivative Tape: Strong unusual activity detected. Review for potential entry. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (CADL 2027 Outlook)

What is the CADL stock price prediction for 2027?

Based on our AI analysis, CADL is predicted to reach $9.03 by 2027, representing a potential 45.6% increase from the current price of $6.20.

Is CADL stock a good buy right now?

Our analysis rates CADL as a HOLD (AI Quant Score 46.6/100) based on current technical and fundamental indicators. With a projected 45.6% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is CADL 52-week high and low?

CADL has a 52-week high of $14.00 and a 52-week low of $4.35. The stock is currently trading 55.7% below its 52-week high.

What is the technical analysis for CADL?

CADL is currently in a downtrend trend. The RSI of 31.1 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.